CANCER OF PROSTATE
Clinical trials for CANCER OF PROSTATE explained in plain language.
Never miss a new study
Get alerted when new CANCER OF PROSTATE trials appear
Sign up with your email to follow new studies for CANCER OF PROSTATE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to supercharge immune system against prostate cancer
Disease control Recruiting nowThis phase II trial tests whether adding an experimental drug called PDS01ADC to standard radiation and hormone therapy can help the immune system fight prostate cancer. About 65 men with high- or intermediate-risk prostate cancer that hasn't spread will take part. Some will get …
Matched conditions: CANCER OF PROSTATE
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New drug cocktail aims to slow prostate cancer spread
Disease control Recruiting nowThis study tests whether adding an experimental drug called PDS01ADC to standard chemotherapy (docetaxel) can help men with prostate cancer that has spread to other parts of the body. About 86 men with either castration-sensitive or castration-resistant metastatic prostate cancer…
Matched conditions: CANCER OF PROSTATE
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Magic mushroom therapy targets Cancer-Related anxiety in new trial
Symptom relief Recruiting nowThis study tests whether a single dose of NPX-5 (a psilocybin drug) combined with talk therapy can reduce severe anxiety in people who have trouble adjusting to a cancer diagnosis. About 87 adults aged 18–80 with moderate-to-severe anxiety will receive one of three doses (25 mg, …
Matched conditions: CANCER OF PROSTATE
Phase: PHASE2 • Sponsor: Psyence Australia Pty Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Could two radiation sessions be as good as five for prostate cancer?
Symptom relief Recruiting nowThis trial compares two different schedules of MRI-guided radiation for men with low or favorable intermediate risk prostate cancer. One group gets the standard five sessions, the other gets just two sessions. The goal is to see if the shorter course can maintain cancer control w…
Matched conditions: CANCER OF PROSTATE
Phase: NA • Sponsor: Sunnybrook Health Sciences Centre • Aim: Symptom relief
Last updated Jun 26, 2026 14:32 UTC
-
10,000 men join quest to decode prostate cancer through scans
Knowledge-focused Recruiting nowThis study is gathering medical records and imaging data from 10,000 men with prostate cancer or at high risk. Researchers aim to find patterns in scans that could help diagnose and treat the disease more effectively. No new drugs or procedures are being tested.
Matched conditions: CANCER OF PROSTATE
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Scientists hunt for genetic clues in prostate cancer blood samples
Knowledge-focused Recruiting nowThis study collects blood samples from 1,000 men with prostate cancer to look for genetic differences that might explain why some cancers stop responding to hormone therapy. Participants give blood at clinic visits, and researchers analyze DNA and other genetic material. No treat…
Matched conditions: CANCER OF PROSTATE
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
7-Day diet or exercise showdown in prostate cancer patients
Knowledge-focused Recruiting nowThis study looks at how a week of either eating less or exercising daily affects prostate tumor growth and muscle health in 45 men with prostate cancer. Participants will be assigned to a reduced-calorie diet, daily exercise with mild diet changes, or their usual routine. After 7…
Matched conditions: CANCER OF PROSTATE
Phase: NA • Sponsor: Maastricht University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC